MoneyWorks4Me

Venus Remedies informs about disclosure on related party transaction

04 Jun 2022 Evaluate

Pursuant to regulation 23(9) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015, Venus Remedies has informed that it enclosed a disclosure on related party transaction on consolidated basis for the half year ended on 31.03.2022.

The above information is a part of company’s filings submitted to BSE.



Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..